Warning: Invalid argument supplied for foreach() in /home/globaldi/public_html/modules/mod_banners/tmpl/default.php on line 9
 

AGS-003 improved OS in unfavorable-risk metastatic renal cell carcinoma - HemOncToday PDF Print
HemOncToday
Adding AGS-003 to sunitinib extended survival for patients with metastatic renal cell carcinoma compared with sunitinib monotherapy, according to results of a phase 2 study. Previous study results showed that AGS-003, a personalized dendritic-cell

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.